Monday, June 15, 2026

Tariff Pressure Pays Off as Japan Commits Billions to U.S. Industry

Trump announces Japan's $550 billion investment in the U.S., including major projects in Texas, Ohio, and Georgia, boosting jobs and security.

Unlocking the Future of Neuroscience: AriBio’s Partnership with Lilly TuneLab for Advanced AI Drug Development

AriBio partners with Eli Lilly's AI platform, Lilly TuneLab, to enhance drug development for neurodegenerative diseases using advanced AI.

SK Innovation and US-based KBR Join Forces to Tackle EU Battery Regulations with New Tech

SK Innovation partners with KBR to commercialize battery recycling technology, aiming for global market leadership in lithium recovery.

Tag: Bayer

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Top News

- Our Sponsors Ad -

Follow us